Achilles Therapeutics has raised more than $175m in its initial public offering on the Nasdaq Global Select Market.

The Seek Group, Laureate Education and BCC-backed online learning platform developer priced its shares at the top of their range.

UK-based biopharmaceutical company raises $75m in IPO

Lava Therapeutics, which is developing cancer treatments based on research at Amsterdam University Medical Centers, floated in a $101m offering.

Novo, Sanofi and Merck & Co all scored exits as the cancer drug developer, which had been spun off by Biox Biosciences, floated in a $101m offering.

The Novo-backed musculoskeletal disease therapy developer floated in an upsized IPO before its share price almost doubled on its first day of trading.

Bristol Myers Squibb has scored an exit from oncology therapy deveoper Ikena, whose share priced doubled on its first day of trading.

The SoftBank-backed automotive e-commerce platform developer ACV Auctions has gone public in an IPO. The company is part of the vehicle marketplace space which has seen much attention from corporate venture investors.

The online question-and-answer platform developer is going public alongside a $250m private placement featuring JD.com, Alibaba, Tencent and Lilith Games.

The University of Utah spinout is looking to float on the Nasdaq Global Select Market and has filed with a $100m placeholder amount.